Show simple item record

dc.contributor.authorGrisso, Thomas
dc.contributor.authorAppelbaum, Paul S.
dc.date2022-08-11T08:10:26.000
dc.date.accessioned2022-08-23T17:09:01Z
dc.date.available2022-08-23T17:09:01Z
dc.date.issued1995-04-01
dc.date.submitted2010-09-10
dc.identifier.citationLaw Hum Behav. 1995 Apr;19(2):149-74.
dc.identifier.issn0147-7307 (Linking)
dc.identifier.pmid11660292
dc.identifier.urihttp://hdl.handle.net/20.500.14038/45716
dc.description.abstractThree instruments assessing abilities related to legal standards for competence to consent to treatment were administered to 6 groups: patients recently hospitalized for schizophrenia, major depression, and ischemic heart disease, as well as three groups of non-ill persons in the community who were matched with the hospitalized patients on age, gender, race, and socioeconomic status. Significant impairments in decisional abilities were found for only a minority of persons in all groups. Both the schizophrenia and depression groups manifested poorer understanding of treatment disclosures, poorer reasoning in decision making regarding treatment, and a greater likelihood of failing to appreciate their illness or the potential benefits of treatment. Deficits were more pronounced, however, among patients with schizophrenia. Implications are discussed for policy designed to protect the rights and welfare of patients with mental illness who are at risk of incompetent refusal or consent when making treatment decisions.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=11660292&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://www.jstor.org/stable/1394305
dc.subjectCognition
dc.subjectCommunication
dc.subjectComprehension
dc.subjectControl Groups
dc.subjectDecision Making
dc.subjectDepressive Disorder
dc.subject*Evaluation Studies as Topic
dc.subjectHeart Diseases
dc.subjectHumans
dc.subject*Informed Consent
dc.subjectInstitutionalization
dc.subjectJurisprudence
dc.subject*Mental Competency
dc.subject*Mentally Ill Persons
dc.subjectMethods
dc.subjectPatients
dc.subjectPsychiatry
dc.subject*Reference Standards
dc.subjectResearch Design
dc.subjectSchizophrenia
dc.subjectTreatment Refusal
dc.subjectUnited States
dc.subjectPsychiatry
dc.titleThe MacArthur Treatment Competence Study. III: Abilities of patients to consent to psychiatric and medical treatments
dc.typeJournal Article
dc.source.journaltitleLaw and human behavior
dc.source.volume19
dc.source.issue2
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/psych_pp/247
dc.identifier.contextkey1550371
html.description.abstract<p>Three instruments assessing abilities related to legal standards for competence to consent to treatment were administered to 6 groups: patients recently hospitalized for schizophrenia, major depression, and ischemic heart disease, as well as three groups of non-ill persons in the community who were matched with the hospitalized patients on age, gender, race, and socioeconomic status. Significant impairments in decisional abilities were found for only a minority of persons in all groups. Both the schizophrenia and depression groups manifested poorer understanding of treatment disclosures, poorer reasoning in decision making regarding treatment, and a greater likelihood of failing to appreciate their illness or the potential benefits of treatment. Deficits were more pronounced, however, among patients with schizophrenia. Implications are discussed for policy designed to protect the rights and welfare of patients with mental illness who are at risk of incompetent refusal or consent when making treatment decisions.</p>
dc.identifier.submissionpathpsych_pp/247
dc.contributor.departmentDepartment of Psychiatry
dc.source.pages149-74


This item appears in the following Collection(s)

Show simple item record